Anne Hedengran
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Cytokine levels and clinical characteristics in the tear fluid of patients with atopic dermatitis and atopic keratoconjunctivitis.
Journal: The ocular surface
Published: December 18, 2024
The use of benzalkonium chloride in topical glaucoma treatment.
Journal: Acta ophthalmologica
Published: November 03, 2023
Effect of chlorhexidine, povidone-iodine and betadine antiseptic eye drops on cultured human conjunctival goblet cell survival.
Journal: Acta ophthalmologica
Published: October 29, 2023
The molecular aspect of anti-glaucomatous eye drops - are we harming our patients?
Journal: Molecular aspects of medicine
Published: May 11, 2023
Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells.
Journal: Journal of optometry
Published: February 21, 2023
IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro.
Journal: Allergy
Published: March 01, 2022
An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival.
Journal: Journal of clinical medicine
Published: February 17, 2022
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement.
Journal: American journal of ophthalmology
Published: January 22, 2022
Impact of benzalkonium chloride-preserved and preservative-free latanoprost eye drops on cultured human conjunctival goblet cells upon acute exposure and differences in physicochemical properties of the eye drops.
Journal: BMJ open ophthalmology
Published: August 31, 2021
Last Updated: 09/26/2026